1. Home
  2. MRVI vs AMCX Comparison

MRVI vs AMCX Comparison

Compare MRVI & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • AMCX
  • Stock Information
  • Founded
  • MRVI 2014
  • AMCX 1980
  • Country
  • MRVI United States
  • AMCX United States
  • Employees
  • MRVI N/A
  • AMCX N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • AMCX Cable & Other Pay Television Services
  • Sector
  • MRVI Health Care
  • AMCX Telecommunications
  • Exchange
  • MRVI Nasdaq
  • AMCX Nasdaq
  • Market Cap
  • MRVI 376.2M
  • AMCX 312.4M
  • IPO Year
  • MRVI 2020
  • AMCX 2011
  • Fundamental
  • Price
  • MRVI $3.34
  • AMCX $7.82
  • Analyst Decision
  • MRVI Hold
  • AMCX Sell
  • Analyst Count
  • MRVI 9
  • AMCX 5
  • Target Price
  • MRVI $4.54
  • AMCX $6.50
  • AVG Volume (30 Days)
  • MRVI 1.4M
  • AMCX 383.8K
  • Earning Date
  • MRVI 11-06-2025
  • AMCX 11-07-2025
  • Dividend Yield
  • MRVI N/A
  • AMCX N/A
  • EPS Growth
  • MRVI N/A
  • AMCX N/A
  • EPS
  • MRVI N/A
  • AMCX N/A
  • Revenue
  • MRVI $219,830,000.00
  • AMCX $2,354,176,000.00
  • Revenue This Year
  • MRVI N/A
  • AMCX N/A
  • Revenue Next Year
  • MRVI $7.23
  • AMCX N/A
  • P/E Ratio
  • MRVI N/A
  • AMCX N/A
  • Revenue Growth
  • MRVI N/A
  • AMCX N/A
  • 52 Week Low
  • MRVI $1.67
  • AMCX $5.41
  • 52 Week High
  • MRVI $8.54
  • AMCX $10.60
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 69.44
  • AMCX 48.76
  • Support Level
  • MRVI $2.94
  • AMCX $7.77
  • Resistance Level
  • MRVI $3.30
  • AMCX $8.16
  • Average True Range (ATR)
  • MRVI 0.20
  • AMCX 0.31
  • MACD
  • MRVI 0.04
  • AMCX -0.09
  • Stochastic Oscillator
  • MRVI 91.98
  • AMCX 7.28

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

Share on Social Networks: